Who makes [^14C]-alisertib?

[^14C]-alisertib is developed by Millennium Pharmaceuticals, Inc..

What development phase is [^14C]-alisertib in?

[^14C]-alisertib is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[^14C]-alisertib

Millennium Pharmaceuticals, Inc. · Phase 1 active Small molecule

At a glance

Generic name	[^14C]-alisertib
Also known as	MLN8237
Sponsor	Millennium Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[^14C]-alisertib CI brief — competitive landscape report
[^14C]-alisertib updates RSS · CI watch RSS
Millennium Pharmaceuticals, Inc. portfolio CI